BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 1714235)

  • 1. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Coutellier A; Ziza JM; Godeau P
    Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.
    Cherin P; Pelletier S; Teixeira A; Laforet P; Genereau T; Simon A; Maisonobe T; Eymard B; Herson S
    Arthritis Rheum; 2002 Feb; 46(2):467-74. PubMed ID: 11840450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of intravenous immunoglobulins in polymyositis and dermatomyositis. An open trial in 15 patients].
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Degennes C; Ziza JM; Du LT; Godeau P
    Presse Med; 1991 Feb; 20(6):244-9. PubMed ID: 1706860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy for refractory myositis.
    Moriguchi M; Suzuki T; Tateishi M; Hara M; Kashiwazaki S
    Intern Med; 1996 Aug; 35(8):663-7. PubMed ID: 8894745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
    Danieli MG; Malcangi G; Palmieri C; Logullo F; Salvi A; Piani M; Danieli G
    Ann Rheum Dis; 2002 Jan; 61(1):37-41. PubMed ID: 11779756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
    Chérin P; Herson S
    Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dramatic effects of high-dose intravenous gammaglobulin in each patient with intractable dermatomyositis and polymyositis].
    Morita R; Nakano K; Hirano Y; Izumi T; Hirayama Y; Suzuki H; Shishikura K; Okada N; Osawa M; Fukuyama Y
    No To Hattatsu; 1989 Nov; 21(6):523-8. PubMed ID: 2478176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of inflammatory myopathies.
    Mastaglia FL; Phillips BA; Zilko P
    Muscle Nerve; 1997 Jun; 20(6):651-64. PubMed ID: 9149071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of dermatomyositis with intravenous gammaglobulin.
    Lang BA; Laxer RM; Murphy G; Silverman ED; Roifman CM
    Am J Med; 1991 Aug; 91(2):169-72. PubMed ID: 1714236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis.
    Saito E; Koike T; Hashimoto H; Miyasaka N; Ikeda Y; Hara M; Yamada H; Yoshida T; Harigai M; Ichikawa Y
    Mod Rheumatol; 2008; 18(1):34-44. PubMed ID: 18217197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis.
    Dalakas MC
    Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.
    Wang DX; Shu XM; Tian XL; Chen F; Zu N; Ma L; Wang GC
    Clin Rheumatol; 2012 May; 31(5):801-6. PubMed ID: 22274797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
    Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
    Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile dermatomyositis: treatment with intravenous gammaglobulin.
    Collet E; Dalac S; Maerens B; Courtois JM; Izac M; Lambert D
    Br J Dermatol; 1994 Feb; 130(2):231-4. PubMed ID: 7510124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.